Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
809 USD | +0.06% | +5.01% | +38.71% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.71% | 728B | |
+33.05% | 603B | |
-5.61% | 360B | |
+18.85% | 332B | |
+1.24% | 279B | |
+16.00% | 244B | |
+8.09% | 207B | |
-5.77% | 205B | |
+6.55% | 164B | |
-0.27% | 122B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Eli Lilly and : , Incyte Say Baricitinib Meets Phase 3 Efficacy Endpoint in Treating Baldness